Exploring liraglutide in lithium-pilocarpine-induced temporal lobe epilepsy model in rats: impact on inflammation, mitochondrial function, and behavior
The medication works by affecting the brains hunger signals, reducing the urge to eat
The study assessed drug utilization and temporal changes in treatment options (e.g., SGLT2i, GLP-1 RA) in adults with CKD and type 2 diabetes regarding two time periods: an earlier period (1 January 201230 June 2021) and a later period after the US approval of finerenone (9 July 202130 September 2023), with the latter period representing updated treatment guidelines, changes to CKD drug labeling (e.g., SGLT2i), and the availability of new CKD-protective medications (ESM Fig
If you prefer to choose your own pharmacy, youll like what LifeRx offers
Starting a GLP-1 medication for weight loss can be an exciting step, but it sometimes comes with unwanted side effects
A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease